Methodology

• Mapping of the Insomnia Severity Index and Other Sleep Measures to EuroQol EQ-5D Health State Utilities

  Date: 30-12-2011  |  Category: Methodology

  Gu NY, Botteman MF, Ji X, Bell CF, Carter JA, van Hout B, Health and Quality of Life Outcomes 2011, 9:119 

  ---

• Leveraging Opportunities in Comparative Effectiveness Research

  Date: 6-9-2010  |  Category: Methodology
  Botteman, M. Next Generation Pharmaceutical.  2010;  Q3; link to pdf.

  ---

• Assessing performance of a randomized versus a non-randomized study design.

  Date: 2-1-2008  |  Category: Methodology
  Raaijmakers M, Koffijberg H, Posthumus J, van Hout B, van Engeland H, Matthys W. Contemp Clin Trials. 2008;29(2):293-303.

  ---

• A probabilistic model for analyzing viral risks of plasma-derived medicinal products.

  Date: 1-1-2008  |  Category: Methodology
  Janssen MP, Over J, van der Poel CL, Cuijpers HT, van Hout BA. Transfusion. 2008;48(1):153-62.

  ---

• Clinical trial registration and the ICMJE.

  Date: 1-1-2005  |  Category: Methodology
  Besselink MG, Gooszen HG, Buskens E. JAMA. 2005;293(2):157-8; author reply 158.

  ---

• Value of cost-utility analysis; evidence-based policy making

  Date: 1-1-2004  |  Category: Methodology
  Buskens E. Ned Tijdschr Geneeskd. 2004;148(22):1074-6. In Dutch.

  ---

• Scaling the sickness impact profile using item response theory: an exploration of linearity, adaptive use, and patient driven item weights.

  Date: 1-1-2004  |  Category: Methodology
  Lindeboom R, Holman R, Dijkgraaf MG, Sprangers MA, Buskens E, Diederiks JP, De Haan RJ. J Clin Epidemiol. 2004;57(1):66-74.

  ---

• A single European currency for EQ-5D health states. Results from a six-country study.

  Date: 1-1-2003  |  Category: Methodology
  Greiner W, Weijnen T, Nieuwenhuizen M, Oppe S, Badia X, Busschbach J, Buxton M, Dolan P, Kind P, Krabbe P, Ohinmaa A, Parkin D, Roset M, Sintonen H, Tsuchiya A, de Charro F. Eur J Health Econ. 2003;4(3):222-31.

  ---

• The measurement and valuation of health status using EQ-5D: a European perspective. Evidence from the EuroQol BIOMED Research Programme.

  Date: 1-1-2001  |  Category: Methodology
  Brooks R, Rabin R, de Charro F. Kluwer Academic Publishers. 2003 ISBN 1-4020-1214-4.

  ---

• A European health status index based on preferences of the general public.

  Date: 1-1-2001  |  Category: Methodology
  de Charro FT, Rabin RE, Weijnen T. Value in Health 2001;4:478.

  ---

• EQ-5D: a measure of health status from the EuroQol Group.

  Date: 1-1-2001  |  Category: Methodology
  Rabin R, de Charro F. Ann Med. 2001;33(5):337-43.

  ---

• 'Medical technology assessment'; more than just efficacy

  Date: 1-1-2000  |  Category: Methodology
  Buskens E. Ned Tijdschr Geneeskd. 2000;144(13):622-6. In Dutch.

  ---

• Sensitivity and perspective in the valuation of health status: whose values count?

  Date: 1-1-2000  |  Category: Methodology
  De Wit GA, Busschbach JJ, De Charro FT. Health Econ. 2000;9(2):109-26.

  ---

• Estimating parametric relationships between health description and health valuation with an application to the EuroQol EQ-5D.

  Date: 1-1-1999  |  Category: Methodology
  Busschbach JJ, McDonnell J, Essink-Bot ML, van Hout BA. J Health Econ. 1999;18(5):551-71.

  ---

• Date:   |  Category: Methodology

  ---